Verve Therapeutics Inc (VERV)
6.35
+0.31
(+5.13%)
USD |
NASDAQ |
Nov 05, 16:00
6.35
0.00 (0.00%)
After-Hours: 16:27
Verve Therapeutics Price to Book Value: 0.9840 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 0.936 |
| November 01, 2024 | 0.9189 |
| October 31, 2024 | 0.8879 |
| October 30, 2024 | 0.8972 |
| October 29, 2024 | 0.9282 |
| October 28, 2024 | 0.9205 |
| October 25, 2024 | 0.9251 |
| October 24, 2024 | 0.8864 |
| October 23, 2024 | 0.8585 |
| October 22, 2024 | 0.8817 |
| October 21, 2024 | 0.86 |
| October 18, 2024 | 0.8755 |
| October 17, 2024 | 0.8461 |
| October 16, 2024 | 0.8678 |
| October 15, 2024 | 0.8662 |
| October 14, 2024 | 0.7795 |
| October 11, 2024 | 0.7237 |
| October 10, 2024 | 0.7128 |
| October 09, 2024 | 0.7082 |
| October 08, 2024 | 0.7004 |
| October 07, 2024 | 0.7423 |
| October 04, 2024 | 0.7748 |
| October 03, 2024 | 0.7314 |
| October 02, 2024 | 0.7438 |
| October 01, 2024 | 0.7423 |
| Date | Value |
|---|---|
| September 30, 2024 | 0.75 |
| September 27, 2024 | 0.7717 |
| September 26, 2024 | 0.7686 |
| September 25, 2024 | 0.7392 |
| September 24, 2024 | 0.7671 |
| September 23, 2024 | 0.7779 |
| September 20, 2024 | 0.8043 |
| September 19, 2024 | 0.8337 |
| September 18, 2024 | 0.8538 |
| September 17, 2024 | 0.8353 |
| September 16, 2024 | 0.8399 |
| September 13, 2024 | 0.8523 |
| September 12, 2024 | 0.8755 |
| September 11, 2024 | 0.9096 |
| September 10, 2024 | 0.8693 |
| September 09, 2024 | 0.8709 |
| September 06, 2024 | 0.867 |
| September 05, 2024 | 0.8569 |
| September 04, 2024 | 0.9453 |
| September 03, 2024 | 0.9422 |
| August 30, 2024 | 1.038 |
| August 29, 2024 | 0.9499 |
| August 28, 2024 | 0.9096 |
| August 27, 2024 | 0.8554 |
| August 26, 2024 | 0.7919 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6818
Minimum
Aug 14 2024
8.759
Maximum
Sep 10 2021
2.986
Average
2.260
Median
Price to Book Value Benchmarks
| Ardelyx Inc | 8.551 |
| Biomarin Pharmaceutical Inc | 2.326 |
| Sage Therapeutics Inc | 0.6580 |
| ALX Oncology Holdings Inc | 0.5009 |
| Immuneering Corp | 0.8855 |
Price to Book Value Related Metrics
| PS Ratio | 24.03 |
| Price | 6.35 |
| Earnings Yield | -40.79% |
| Market Cap | 537.37M |